| Application no. and date | 13157573.0 (espacenet) (Federated) (European Patent Register), 20070928 | | Patent/reg. no. and date | DK/EP 2601970, 20161026 | | Publication date | 20130612 | | Priority no. and date | US 847912 P, 20060929, US 973392 P, 20070918 | | EP pub. no. and date |
EP 2601970 20130612 | | Effective date | | | Applicant/owner | Takeda Vaccines, Inc., 75 Sidney Street
Cambridge, MA 02139, US | | Applicant ref. no. | 60846DK01 | | Inventor | Richardson, Charles, c/o Takeda Vaccines, Inc.
One Takeda Parkway
Deerfield, IL 60015, US,
Vedvick, Thomas S., c/o Takeda Vaccines, Inc.
One Takeda Parkway
Deerfield, IL 60015, US,
Foubert, Thomas R., c/o Takeda Vaccines, Inc.
One Takeda Parkway
Deerfield, IL 60015, US,
Tino, William T., c/o Takeda Vaccines, Inc.
One Takeda Parkway
Deerfield, IL 60015, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 39/12 (2006.01) , A61K 39/42 (2006.01) | | Title | Norovirus-vaccine-formuleringer | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
